OCUL Stock Price
OCUL
OCUL stock price is $6.60 (+2.57% on the day), giving OCUL a market cap of $1.41B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
OCUL Stock Overview
- Price
- $6.59
- Previous close
- $6.43
- Open
- $6.53
- Market cap
- $1.41B
- 1-year price target
- $25.67
- MarketXLS Rank
- 54
About OCUL
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of wet age-related macular degeneration and in Phase 1 clinical trials for the treatment of non-proliferative diabetic retinopathy; PAXTRAVA, a travoprost intracameral hydrogel, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension. The company has a license agreement and collaboration with AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and PAXTRAVA. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OCUL | $6.60 | +2.6% | 1.96M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |